COMPARISON OF FLUOXETINE AND IMIPRAMINE FOR MIGRAINE HEADACHE

Q: How can I download an article?

To download an article from SID, first log in to the site, search for the article title, and click on the 'Download Article' option.

Q: How can I download an ISI article?

To download an ISI article on SID, enter the keyword or article title in the search bar, view the relevant results, click on the desired article, and select the 'Download Article' option.

Q: How can I access the SID database?

To access the SID database, visit SID.ir, create an account, and log in to access scientific resources.

Q: Is downloading articles from SID free?

Some articles on SID are available for free, while others require payment. Details are specified on the article's page.

ABUTALEBI S.; ZENDEHBOUDI S.

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Journal Paper

Paper Information

Journal: Iranian South Medical Journal Year:2001 | Volume:4 | Issue:1 Page(s): 11-15

Download Full-Text

Persian Verion

View:

20,373

Download:

Cites:

Information Journal Paper

Title

COMPARISON OF FLUOXETINE AND IMIPRAMINE FOR MIGRAINE HEADACHE

Author(s)

ABUTALEBI S. | ZENDEHBOUDI S. | Issue Writer Certificate

Keywords

FLUOXETINEQ3

IMIPRAMINEQ3

MIGRAINEQ2

HEADACHEQ3

Abstract

In this single-blind clinical trial, 68 patients with criteria of International Society of HEADACHE suffered from at least two HEADACHE attacks per month were divided into two groups who were similar in sex, age, severity and number of headahe attacks per month. FLUOXETINE (20 mg per day) for experimental group and IMIPRAMINE (50 mg per day), for the other group were prescribed for 12 weeks. During study, 8 patients in control group and 10 patients in FLUOXETINE group discontinued the trial due to adverse drug effects (P>0.05). There was no significant HEADACHE attacks between FLUOXETINE group [6.94±2.85headache attacks per month before treatment which changed to 3.48±3.11 attacks per month; p<0.05] and IMIPRAMINE group [Z30±3.11 attacks per month to 3.08±2.84 attacks per month; p<0.05] (p>0.05). The severity of HEADACHE attacks were decreased in both groups, however, there was no difference between groups. FLUOXETINE has no contraindication in pregnancy, it could be prescribed in single dose. Therefore, it is recommended as a prophylactic choice measure for MIGRAINE HEADACHE.

Cites

No record.

References

No record.

Cite

APA: Copy

ABUTALEBI, S., & ZENDEHBOUDI, S.. (2001). COMPARISON OF FLUOXETINE AND IMIPRAMINE FOR MIGRAINE HEADACHE. IRANIAN SOUTH MEDICAL JOURNAL (ISMJ), 4(1), 11-15. SID. https://sid.ir/paper/33982/en

Vancouver: Copy

ABUTALEBI S., ZENDEHBOUDI S.. COMPARISON OF FLUOXETINE AND IMIPRAMINE FOR MIGRAINE HEADACHE. IRANIAN SOUTH MEDICAL JOURNAL (ISMJ)[Internet]. 2001;4(1):11-15. Available from: https://sid.ir/paper/33982/en

IEEE: Copy

S. ABUTALEBI, and S. ZENDEHBOUDI, “COMPARISON OF FLUOXETINE AND IMIPRAMINE FOR MIGRAINE HEADACHE,” IRANIAN SOUTH MEDICAL JOURNAL (ISMJ), vol. 4, no. 1, pp. 11–15, 2001, [Online]. Available: https://sid.ir/paper/33982/en

Related Journal Papers